United States Digital Pathology Market Insight
Published: 29 June 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The United States Digital Pathology Market is projected to grow at a CAGR of around 11.2%, driven by increasing adoption of whole-slide imaging systems and digital healthcare technologies.
United States Digital Pathology Market Forecasts to 2035
- The United States Digital Pathology Market size was estimated at approximately USD 1.85 Billion in 2025.
- The market is expected to grow at a CAGR of around 11.2% from 2025 to 2035.
- The United States Digital Pathology Market is projected to reach approximately USD 5.34 Billion by 2035.
Notable Insights for the United States Digital Pathology Market
- Segmentation based on product indicates that Whole Slide Imaging (WSI) Systems and Image Management Software account for approximately 46% of market revenue in 2025, supported by increasing digitization of pathology laboratories and diagnostic workflows.
- Segmentation based on application shows that Disease Diagnosis, Cancer Detection, and Drug Discovery hold nearly 63% market share in 2025, driven by rising demand for accurate diagnostics, precision oncology, and pharmaceutical research.
- The market is increasingly influenced by artificial intelligence and machine learning technologies, with AI-assisted image analysis, automated tissue classification, and predictive diagnostic tools accounting for over 42% of newly deployed digital pathology solutions in 2025.
- Growing investments in telepathology, cloud-based pathology platforms, and integrated laboratory information systems have accelerated digital transformation, contributing nearly 45% of new capital expenditures within the industry.
Download the eBook (ToC)
Why Buy This Report
- Provides comprehensive analysis of demand across digital pathology systems, image management software, AI-enabled diagnostic platforms, and end-user applications.
- Covers detailed insights into whole-slide imaging technologies, telepathology solutions, laboratory information systems, cloud-based pathology platforms, and AI-assisted diagnostic tools.
- Helps stakeholders evaluate competitive positioning, investment opportunities, and growth potential within the United States digital pathology ecosystem.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States Digital Pathology Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Digital Pathology Market
- Leica Biosystems
- Philips Healthcare
- Roche Diagnostics
- Hamamatsu Photonics K.K.
- Olympus Corporation
- Fujifilm Holdings Corporation
- Hologic, Inc.
- 3DHISTECH Ltd.
- Indica Labs, Inc.
- Proscia Inc.
Recent Developments:
- In May 2025, Philips Healthcare expanded its AI-powered digital pathology portfolio by introducing advanced image analysis capabilities to improve cancer diagnosis and laboratory efficiency.
- In February 2025, Leica Biosystems enhanced its digital pathology platform through the integration of cloud-enabled collaboration tools and AI-assisted workflow solutions for pathology laboratories across the United States.
Market Segmentation:
United States Digital Pathology Market, By Product
- Whole Slide Imaging (WSI) Systems
- Image Management Software
- Digital Microscopes
- Storage & Communication Systems
United States Digital Pathology Market, By Application
- Disease Diagnosis
- Drug Discovery & Development
- Academic Research
- Telepathology
United States Digital Pathology Market, By End User
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
Expert Views:
The United States Digital Pathology Market is expected to witness robust growth through 2035, supported by increasing adoption of AI-enabled diagnostic technologies, growing demand for precision medicine, and continued digitization of pathology laboratories. Advancements in whole-slide imaging, cloud-based pathology platforms, telepathology, and automated image analysis are anticipated to strengthen long-term market growth. Furthermore, rising prevalence of cancer, increasing healthcare digitalization, and expanding research activities are expected to create significant opportunities for pathology solution providers, healthcare organizations, pharmaceutical companies, and technology vendors throughout the United States.
Author: Govind and Krishna By Decisions Advisors and Consulting